Kwangdong Healthbio Co., Ltd. (XKON:086220)
1,468.00
-32.00 (-2.13%)
At close: Aug 1, 2025, 3:30 PM KST
bluebird bio Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | 2005 - 2009 |
---|---|---|---|---|---|---|
Period Ending | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | 2005 - 2009 |
Cash & Equivalents | 1,280 | 260.73 | 156.22 | 279.86 | 250.6 | Upgrade |
Short-Term Investments | - | 100 | 100 | - | - | Upgrade |
Cash & Short-Term Investments | 1,280 | 360.73 | 256.22 | 279.86 | 250.6 | Upgrade |
Cash Growth | 254.93% | 40.79% | -8.45% | 11.68% | -84.08% | Upgrade |
Accounts Receivable | 4,066 | 5,951 | 3,332 | 8,411 | 8,251 | Upgrade |
Other Receivables | 129.15 | 171.3 | 542.45 | 1,307 | 1,567 | Upgrade |
Receivables | 4,297 | 6,228 | 5,232 | 12,031 | 13,433 | Upgrade |
Inventory | 5,731 | 4,440 | 4,889 | 8,975 | 8,108 | Upgrade |
Prepaid Expenses | 1,155 | 989.54 | 695.78 | 1,227 | 1,236 | Upgrade |
Other Current Assets | 798.52 | 1,059 | 1,052 | 1,718 | 2,582 | Upgrade |
Total Current Assets | 13,261 | 13,077 | 12,125 | 24,231 | 25,610 | Upgrade |
Property, Plant & Equipment | 21,674 | 22,868 | 24,056 | 24,598 | 18,991 | Upgrade |
Long-Term Investments | 1,579 | 1,513 | 1,204 | 1,545 | 1,069 | Upgrade |
Other Intangible Assets | 423.45 | 451.82 | 436.09 | 450.18 | 462.51 | Upgrade |
Long-Term Deferred Tax Assets | 994.54 | 485.78 | 357.72 | 606.7 | 561.72 | Upgrade |
Long-Term Deferred Charges | 794.91 | 972.9 | 1,105 | 1,106 | 703.57 | Upgrade |
Other Long-Term Assets | 548.75 | 548.05 | 185.15 | 207.55 | 872.35 | Upgrade |
Total Assets | 39,276 | 39,916 | 39,469 | 52,745 | 48,270 | Upgrade |
Accounts Payable | 2,097 | 1,856 | 1,414 | 2,516 | 4,501 | Upgrade |
Accrued Expenses | 779.79 | 1,474 | 1,627 | 974.28 | 708.8 | Upgrade |
Short-Term Debt | 18,129 | 24,154 | 21,062 | 19,045 | 14,005 | Upgrade |
Current Portion of Long-Term Debt | 375 | 1,442 | 6,535 | 5,181 | 6,753 | Upgrade |
Current Income Taxes Payable | 251.72 | 156.72 | 8.52 | 131.28 | 56.73 | Upgrade |
Current Unearned Revenue | 71.29 | - | - | - | - | Upgrade |
Other Current Liabilities | 3,602 | 4,531 | 2,776 | 4,182 | 3,630 | Upgrade |
Total Current Liabilities | 25,306 | 33,614 | 33,422 | 32,029 | 29,654 | Upgrade |
Long-Term Debt | 957.24 | 1,457 | 1,014 | 4,368 | 3,247 | Upgrade |
Other Long-Term Liabilities | 251.53 | 395.88 | 220.7 | 311.25 | 208.72 | Upgrade |
Total Liabilities | 27,445 | 36,152 | 35,170 | 37,133 | 33,418 | Upgrade |
Common Stock | 3,692 | 2,763 | 2,763 | 4,215 | 4,215 | Upgrade |
Additional Paid-In Capital | 13,092 | 5,597 | 5,597 | 8,539 | 8,539 | Upgrade |
Retained Earnings | 2,414 | 2,771 | 3,305 | 2,857 | 2,098 | Upgrade |
Treasury Stock | -0.19 | -0.19 | -0.19 | - | - | Upgrade |
Comprehensive Income & Other | -7,367 | -7,367 | -7,367 | -0 | 0 | Upgrade |
Shareholders' Equity | 11,831 | 3,764 | 4,299 | 15,612 | 14,853 | Upgrade |
Total Liabilities & Equity | 39,276 | 39,916 | 39,469 | 52,745 | 48,270 | Upgrade |
Total Debt | 19,461 | 27,052 | 28,611 | 28,594 | 24,005 | Upgrade |
Net Cash (Debt) | -18,181 | -26,692 | -28,355 | -28,314 | -23,755 | Upgrade |
Net Cash Per Share | -3203.25 | -4837.77 | -3954.78 | -3341.59 | -2816.37 | Upgrade |
Filing Date Shares Outstanding | 5.68 | 5.52 | 7.17 | 8.47 | 8.45 | Upgrade |
Total Common Shares Outstanding | 5.68 | 5.52 | 7.17 | 8.47 | 8.45 | Upgrade |
Working Capital | -12,045 | -20,537 | -21,297 | -7,798 | -4,045 | Upgrade |
Book Value Per Share | 2084.52 | 682.25 | 599.61 | 1842.47 | 1757.15 | Upgrade |
Tangible Book Value | 11,408 | 3,312 | 3,863 | 15,161 | 14,390 | Upgrade |
Tangible Book Value Per Share | 2009.91 | 600.36 | 538.79 | 1789.34 | 1702.44 | Upgrade |
Land | 5,980 | 5,980 | 6,068 | 6,068 | 3,133 | Upgrade |
Buildings | 15,093 | 15,093 | 15,348 | 15,109 | 13,581 | Upgrade |
Machinery | 9,360 | 9,235 | 8,739 | 8,208 | 6,005 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.